Wednesday, July 8, 2026

pharma · Urea cycle disorders (UCD) · Cannabis Smoking · CAMP

Camp4 Therapeutics

Camp4 Therapeutics clinical programs — 2 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Cambridge, USA HQ
2016 Founded
60 Employees
Public company Type
CAMP · NYSE Ticker
Company details
Status
Public
HQ
Cambridge, USA
Founded
2016
Employees
60
Programs
9
Drugs
15
Patents
4
Intelligence · Clinical Programs

Camp4 Therapeutics projects

2 ClinicalTrials.gov programs sponsored by Camp4 Therapeutics.

Camp4 Therapeutics has 2 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Active smoked cannabis

    Camp4 Therapeutics Corp

    Cannabis Smoking

    phase 2 small molecule active

    1 trial
  2. Treatment as Usual

    Camp4 Therapeutics Corp

    Post-Traumatic Stress Disorder

    phase 2 other completed

    1 trial

Frequently asked questions

How many clinical projects does Camp4 Therapeutics have?

2 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.